We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.



SARS-CoV-2 Omicron Spike Protein and Antibodies Available

SARS-CoV-2 Omicron Spike Protein and Antibodies Available

Several new variants of SARS-CoV-2 virus have emerged in recent months. The Alpha, Gamma, Beta, Delta, and the most recent Omicron are particular concerning because of their high prevalence. A subset of the mutations identified in the RBD domain of the spike protein occurs in more than one strain. These convergent mutations are of high interest because they may be the cause of the increased transmissibility. Sino Biological has launched RBD and Spike proteins of these variants.

SARS-CoV-2 Omicron Spike Protein & Antibodies Available

Sino Biological has developed recombinant Omicron Spike RBD Protein and Antibody reacting with Omicron to support the study of Omicron variant. More Omicron antigens, including B.1.1.529 S-ECD, S1, and Nucleocapsid, are coming soon.

Recombinant RBD/Spike and Nucleocapsid Protein Variants

Sino Biological has developed a panel of recombinant RBD/Spike and nucleocapsid protein variants which can be used to evaluate the efficacy of the antibodies and vaccination.

Learn More Recombinant SARS-CoV-2 Variants

About Sino Biological
Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones.
Interested in seeing more content from Sino Biological?
Discover all their latest news, webinars, products and more by clicking the link below.